158 related articles for article (PubMed ID: 22183457)
1. Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime.
Ayres DC; Fedele TA; Marcucci MC; Giorgio S
Rev Inst Med Trop Sao Paulo; 2011; 53(6):329-34. PubMed ID: 22183457
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
Nilforoushzadeh MA; Shirani-Bidabadi L; Zolfaghari-Baghbaderani A; Saberi S; Siadat AH; Mahmoudi M
J Vector Borne Dis; 2008 Dec; 45(4):301-6. PubMed ID: 19248657
[TBL] [Abstract][Full Text] [Related]
3. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
4. Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.
da Silva SS; Mizokami SS; Fanti JR; Miranda MM; Kawakami NY; Teixeira FH; Araújo EJ; Panis C; Watanabe MA; Sforcin JM; Pavanelli WR; Verri WA; Felipe I; Conchon-Costa I
Parasitol Res; 2016 Apr; 115(4):1557-66. PubMed ID: 26711452
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.
Harms G; Chehade AK; Douba M; Roepke M; Mouakeh A; Rosenkaimer F; Bienzle U
Trans R Soc Trop Med Hyg; 1991; 85(2):214-6. PubMed ID: 1909469
[TBL] [Abstract][Full Text] [Related]
6. The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.
Macedo SR; de Figueiredo Nicolete LD; Ferreira Ados S; de Barros NB; Nicolete R
Int Immunopharmacol; 2015 Sep; 28(1):554-9. PubMed ID: 26218282
[TBL] [Abstract][Full Text] [Related]
7. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
Sadeghian G; Nilforoushzadeh MA
Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis].
Costa Filho AV; Lucas IC; Sampaio RN
Rev Soc Bras Med Trop; 2008; 41(4):424-7. PubMed ID: 18853022
[TBL] [Abstract][Full Text] [Related]
11. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A
Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
[TBL] [Abstract][Full Text] [Related]
13. Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
Bahrami S; Esmaeilzadeh S; Zarei M; Ahmadi F
Parasitol Res; 2015 Dec; 114(12):4617-24. PubMed ID: 26346452
[TBL] [Abstract][Full Text] [Related]
14. Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.
Ferreira FM; Castro RA; Batista MA; Rossi FM; Silveira-Lemos D; Frézard F; Moura SA; Rezende SA
Parasitol Res; 2014 Feb; 113(2):533-43. PubMed ID: 24292604
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Solgi G; Kariminia A; Abdi K; Darabi M; Ghareghozloo B
Korean J Parasitol; 2006 Mar; 44(1):55-61. PubMed ID: 16514283
[TBL] [Abstract][Full Text] [Related]
16. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
[TBL] [Abstract][Full Text] [Related]
17. Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A
Trop Med Parasitol; 1992 Dec; 43(4):219-22. PubMed ID: 1293723
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
[TBL] [Abstract][Full Text] [Related]
19. The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.
Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Veloso LB; Santini Pereira BA; Cysne-Finkelstein L; Lechuga GC; Bourguignon SC; Almeida-Souza F; da Silva Calabrese K; Ferreira VF; Alves CR
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():101-108. PubMed ID: 31430693
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
Salmanpour R; Handjani F; Nouhpisheh MK
J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]